Literature DB >> 9409445

Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease.

T K Inoue1, K Ikezaki, T Sasazuki, T Matsushima, M Fukui.   

Abstract

Moyamoya disease is a progressive steno-occlusive disease at the terminal portion of the bilateral internal carotid arteries. An unusual vascular network is formed as a result of ischemic change of cerebrovascular system. Although some investigations suggested possible etiological factors of Moyamoya disease, the etiology is still unknown. To elucidate the genetic factors of Moyamoya disease, class II genes of human leukocyte antigen (HLA) were analyzed at the DNA level. The DNA typing of HLA was performed in the unrelated Japanese patients with definite Moyamoya disease using extracted genomic DNA from the leukocyte. The genotype was confirmed by polymerase chain reaction-sequence specific oligonucleotide probe (PCR-SSOP) technique. The class II genotypes were analyzed in 71 samples. As a result, several alleles of class II genes showed significant association with Moyamoya disease. DQB1*0502 had positive association with the disease. On the other hand DRB1*0405 and DQB1*0401 had negative association. Moyamoya disease seems to have a genetic background in its etiology because certain alleles of HLA are associated with Moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409445     DOI: 10.1016/s0303-8467(97)00051-6

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

1.  Adult unilateral moyamoya disease with familial occurrence in two definite cases: a case report and review of the literature.

Authors:  Noboru Kusaka; Takashi Tamiya; Yoshiaki Adachi; Shinji Katayama; Shimpei Namba; Koji Tokunaga; Kenji Sugiu; Isao Date; Takashi Ohmoto
Journal:  Neurosurg Rev       Date:  2005-07-15       Impact factor: 3.042

Review 2.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

3.  Association of HLA-DR and -DQ Genes with Familial Moyamoya Disease in Koreans.

Authors:  Seok Ho Hong; Kyu-Chang Wang; Seung-Ki Kim; Byung-Kyu Cho; Myoung Hee Park
Journal:  J Korean Neurosurg Soc       Date:  2009-12-31

4.  Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.

Authors:  Ryosuke Tashiro; Kuniyasu Niizuma; Seik-Soon Khor; Katsushi Tokunaga; Miki Fujimura; Hiroyuki Sakata; Hidenori Endo; Hidetoshi Inoko; Koetsu Ogasawara; Teiji Tominaga
Journal:  PLoS One       Date:  2019-08-14       Impact factor: 3.240

5.  Association of HLA-DQA2 and HLA-B With Moyamoya Disease in the Chinese Han Population.

Authors:  Jiang Wan; Wei Ling; Zhang Zhengshan; Zuo Xianbo; Duan Lian; Wang Kai
Journal:  Neurol Genet       Date:  2021-06-02

Review 6.  The Genetic Basis of Moyamoya Disease.

Authors:  R Mertens; M Graupera; H Gerhardt; A Bersano; E Tournier-Lasserve; M A Mensah; S Mundlos; P Vajkoczy
Journal:  Transl Stroke Res       Date:  2021-09-16       Impact factor: 6.829

Review 7.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.